We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
+43.29%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$2.75B
AUM Growth
+$811M
(+42%)
Cap. Flow
+$363M
Cap. Flow
% of AUM
13.21%
Top 10 Holdings %
Top 10 Hldgs %
44.65%
Holding
241
New
88
Increased
39
Reduced
33
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDVL
MedAvail Holdings, Inc. Common Stock
MDVL
|
+$36.2M |
| 2 |
Hydrofarm Holdings
HYFM
|
+$19.6M |
| 3 |
Pulmonx
LUNG
|
+$19.2M |
| 4 |
Seer Inc
SEER
|
+$18.7M |
| 5 |
AbCellera Biologics
ABCL
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cooper Companies
COO
|
+$27M |
| 2 |
Inspire Medical Systems
INSP
|
+$11.3M |
| 3 |
PPD
PPD, Inc. Common Stock
PPD
|
+$11.1M |
| 4 |
STAAR Surgical
STAA
|
+$10.4M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$9.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.42% |
| 2 | Industrials | 1.65% |
| 3 | Consumer Staples | 0.32% |
| 4 | Financials | 0.08% |
| 5 | Materials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
PUT
Cigna
CI
$72.8B
| $20.8M | 0.76% |
+100,000
| New | +$19.6M |
|
27
PUT
First Trust Health Care AlphaDEX Fund
FXH
$1.11B
| $20.5M | 0.74% |
190,000
-177,500
| -48% | -$18.1M |
|
28
Natera
NTRA
$45.4B
| $20.2M | 0.73% |
202,500
+12,500
| +7% | +$1.04M |
|
29
Pacific Biosciences
PACB
$339M
| $20.1M | 0.73% |
776,030
-223,970
| -22% | -$3.81M |
|
30
Guardant Health
GH
$22B
| $19.9M | 0.72% |
154,092
+80,000
| +108% | +$9.2M |
|
|
31
Hydrofarm Holdings
HYFM
$7.96M
| $19.7M | 0.72% |
+37,500
| New | +$19.6M |
|
|
XENT
32
DELISTED
Intersect ENT, Inc
XENT
| $19.6M | 0.71% |
855,723
-5,093
| -0.6% | -$97K |
|
|
ALXN
33
DELISTED
Alexion Pharmaceuticals
ALXN
| $19.4M | 0.7% |
123,896
-72,400
| -37% | -$9.3M |
|
34
PUT
DexCom
DXCM
$34B
| $18.5M | 0.67% |
200,000
+32,000
| +19% | +$2.86M |
|
|
FOLD
35
CALL
DELISTED
Amicus Therapeutics
FOLD
| $18.5M | 0.67% |
800,000
+200,000
| +33% | +$4.09M |
|
36
Adaptive Biotechnologies
ADPT
$3.97B
| $17.7M | 0.64% |
299,898
+76,498
| +34% | +$3.94M |
|
37
SI-BONE Inc
SIBN
$841M
| $17.4M | 0.63% |
583,559
+125,050
| +27% | +$3.04M |
|
38
PUT
Stryker
SYK
$133B
| $17.2M | 0.62% |
70,000
+20,000
| +40% | +$4.53M |
|
39
LivaNova
LIVN
$4.48B
| $17.1M | 0.62% |
+258,803
| New | +$14.4M |
|
40
CALL
Eli Lilly
LLY
$1.09T
| $16.9M | 0.61% |
+100,000
| New | +$14.9M |
|
|
41
Seer Inc
SEER
$118M
| $16.5M | 0.6% |
+293,600
| New | +$18.7M |
|
|
PROF
42
Profound Medical
PROF
$255M
| $16M | 0.58% |
780,567
| – | – |
|
|
NSTG
43
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
| $16M | 0.58% |
239,300
+139,300
| +139% | +$6.99M |
|
44
PUT
Quest Diagnostics
DGX
$26.2B
| $15.5M | 0.56% |
130,000
+60,000
| +86% | +$7.31M |
|
|
INOV
45
CALL
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $15.2M | 0.55% |
836,600
+636,600
| +318% | +$13.6M |
|
|
IMDX
46
Insight Molecular Diagnostics
IMDX
$144M
| $15M | 0.55% |
314,141
+13,014
| +4% | +$477K |
|
|
IVC
47
DELISTED
Invacare Corporation
IVC
| $14.8M | 0.54% |
1,653,941
-15,084
| -0.9% | -$125K |
|
48
CALL
Illumina
ILMN
$28.9B
| $14.8M | 0.54% |
+41,120
| New | +$13.1M |
|
|
49
AbCellera Biologics
ABCL
$3.07B
| $14.7M | 0.53% |
+365,000
| New | +$16.7M |
|
|
QTNT
50
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $14.4M | 0.52% |
69,206
-7,166
| -9% | -$1.67M |
|
Similar funds
BCA
RC
DOFI
SCI
LPC
GBCP
SCTC
M
Pura Vida Investments's Q4 2020 Portfolio in Review
As of Q4 2020, Pura Vida Investments held 241 positions worth $2.75B, up 42% from $1.94B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Pura Vida Investments deployed $363M of net new capital in Q4 2020, opening 88 new positions and adding to 39 existing holdings. Its largest new stake was MedAvail Holdings, Inc. Common Stock: 51,760 shares worth $36.9M.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 32% a quarter earlier, followed by Industrials and Consumer Staples.
On the sell side, the largest reduction was Inspire Medical Systems, an estimated $11.3M trimmed.
- Pura Vida Investments's largest Q4 2020 buy was MedAvail Holdings, Inc. Common Stock: 51,760 shares worth $36.9M.
- Pura Vida Investments added most to Guardant Health in Q4 2020, an estimated $9.2M increase.
- Pura Vida Investments's biggest Q4 2020 reduction was Inspire Medical Systems, cutting an estimated $11.3M.
- Pura Vida Investments fully exited Cooper Companies in Q4 2020, selling an estimated $27M.
- Pura Vida Investments's ten largest holdings make up 45% of its $2.75B portfolio in Q4 2020.
- Pura Vida Investments opened 88 new positions and closed 64 in Q4 2020.
- Pura Vida Investments's portfolio value rose 42% quarter-over-quarter to $2.75B.
Based on Pura Vida Investments's 13F filing for Q4 2020, filed 16 Feb 2021.